Market Research Logo

Actelion Ltd - Product Pipeline Review - 2016

Actelion Ltd - Product Pipeline Review - 2016

Summary



Global Markets Direct’s, ‘Actelion Ltd - Product Pipeline Review - 2016’, provides an overview of the Actelion Ltd’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Actelion Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Actelion Ltd
  • The report provides overview of Actelion Ltd including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Actelion Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Actelion Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Actelion Ltd’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Actelion Ltd
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Actelion Ltd’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Actelion Ltd Snapshot
Actelion Ltd Overview
Key Information
Key Facts
Actelion Ltd - Research and Development Overview
Key Therapeutic Areas
Actelion Ltd - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Actelion Ltd - Pipeline Products Glance
Actelion Ltd - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Actelion Ltd - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Actelion Ltd - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Actelion Ltd - Drug Profiles
mechlorethamine hydrochloride
Product Description
Mechanism of Action
R&D Progress
selexipag
Product Description
Mechanism of Action
R&D Progress
cadazolid
Product Description
Mechanism of Action
R&D Progress
macitentan
Product Description
Mechanism of Action
R&D Progress
ponesimod
Product Description
Mechanism of Action
R&D Progress
miglustat
Product Description
Mechanism of Action
R&D Progress
clazosentan
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Antagonize Endothelin Receptor A and Endothelin Receptor B for Essential Hypertension
Product Description
Mechanism of Action
R&D Progress
Cenerimod
Product Description
Mechanism of Action
R&D Progress
AC-082
Product Description
Mechanism of Action
R&D Progress
ACT-451840
Product Description
Mechanism of Action
R&D Progress
ACT-541468
Product Description
Mechanism of Action
R&D Progress
lucerastat
Product Description
Mechanism of Action
R&D Progress
Small Molecule 2 for Neurological Disorders
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Cardiovascular Disorders
Product Description
Mechanism of Action
R&D Progress
AC-080
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Antagonize Orexin 2 Receptor for Sleep Disorders
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit DNA Gyrase and Topoisomerase IV for Bacterial Infection
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Hypertension
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Antagonize Endothelin A Receptor for Hypertension
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit DNA Ligase for Staphylococcal Infections
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Cancer
Product Description
Mechanism of Action
R&D Progress
Actelion Ltd - Pipeline Analysis
Actelion Ltd - Pipeline Products by Target
Actelion Ltd - Pipeline Products by Route of Administration
Actelion Ltd - Pipeline Products by Molecule Type
Actelion Ltd - Pipeline Products by Mechanism of Action
Actelion Ltd - Recent Pipeline Updates
Actelion Ltd - Dormant Projects
Actelion Ltd - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
almorexant
selexipag
Actelion Ltd - Company Statement
Actelion Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Actelion Ltd, Key Information
Actelion Ltd, Key Facts
Actelion Ltd - Pipeline by Indication, 2016
Actelion Ltd - Pipeline by Stage of Development, 2016
Actelion Ltd - Monotherapy Products in Pipeline, 2016
Actelion Ltd - Partnered Products in Pipeline, 2016
Actelion Ltd - Partnered Products/ Combination Treatment Modalities, 2016
Actelion Ltd - Out-Licensed Products in Pipeline, 2016
Actelion Ltd - Out-Licensed Products/ Combination Treatment Modalities, 2016
Actelion Ltd - Pre-Registration, 2016
Actelion Ltd - Phase III, 2016
Actelion Ltd - Phase II, 2016
Actelion Ltd - Phase I, 2016
Actelion Ltd - Preclinical, 2016
Actelion Ltd - Discovery, 2016
Actelion Ltd - Pipeline by Target, 2016
Actelion Ltd - Pipeline by Route of Administration, 2016
Actelion Ltd - Pipeline by Molecule Type, 2016
Actelion Ltd - Pipeline Products by Mechanism of Action, 2016
Actelion Ltd - Recent Pipeline Updates, 2016
Actelion Ltd - Dormant Developmental Projects,2016
Actelion Ltd - Discontinued Pipeline Products, 2016
Actelion Ltd, Subsidiaries
List of Figures
Actelion Ltd - Pipeline by Top 10 Indication, 2016
Actelion Ltd - Pipeline by Stage of Development, 2016
Actelion Ltd - Monotherapy Products in Pipeline, 2016
Actelion Ltd - Partnered Products in Pipeline, 2016
Actelion Ltd - Pipeline by Top 10 Target, 2016
Actelion Ltd - Pipeline by Route of Administration, 2016
Actelion Ltd - Pipeline by Molecule Type, 2016
Actelion Ltd - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report